Lilly, Novo Nordisk back direct-to-employer programs to expand access to weight-loss drugs

(Reuters) -Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access to its blockbuster weight-loss drug through partnerships with third-party firms. The program would give employers flexible cost-sharing options and integrate clinical support, Lilly said, bypassing traditional drug sales channels. “Obesity care is…

Read More